Back to top

Hutchmed price target lowered to $17 from $20 at BofA

BofA analyst Alec Stranahan lowered the firm’s price target on Hutchmed (HCM) to $17 from $20 and keeps a Buy rating on the shares. The print will ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HUTCHMED (China) Limited Sponsored ADR (HCM)